Literature DB >> 35535065

Progressive Familial Intrahepatic Cholestasis: Need for Genetic Analysis Before Liver Transplantation.

Bikrant B Lal1, Vikrant Sood1, Kavita Jain2, Chhagan Bihari2, Rajeev Khanna1, Seema Alam1.   

Abstract

The clinical course after liver transplantation (LT) in progressive familial intrahepatic cholestasis type 1 (PFIC1) is complicated by intractable diarrhoea, growth failure, graft steatosis and cirrhosis. Recent evidence from Japan suggests the role of genotype to predict outcome after LT. We report a case with pathogenic frameshift mutation who had failed partial external biliary diversion, underwent LT and his post-LT course has been complicated by intractable diarrhoea, growth failure, steatosis and fibrosis. This case highlights the fact that homozygous frameshift p.Gly197LeufsTer10 mutation in ATP8B1 is associated with poor outcome and genetic evaluation should be mandatory before subjecting the patient to LT.
© 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V.

Entities:  

Keywords:  ESLD, end-stage liver disease; LT, liver transplant; PFIC, progressive familial intrahepatic cholestasis; POD, postoperative day; TPN, total parenteral nutrition; cholestasis; graft biopsy; liver transplantation; progressive familial intrahepatic 1

Year:  2021        PMID: 35535065      PMCID: PMC9077163          DOI: 10.1016/j.jceh.2021.06.009

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  7 in total

1.  Long-term Outcomes of Living-donor Liver Transplantation for Progressive Familial Intrahepatic Cholestasis Type 1.

Authors:  Tatsuya Okamoto; Mari Sonoda; Eri Ogawa; Shogo Ito; Takao Togawa; Hisamitsu Hayashi; Hideaki Okajima; Shiji Uemoto
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-03-01       Impact factor: 2.839

2.  Liver Steatosis and Diarrhea After Liver Transplantation for Progressive Familial Intrahepatic Cholestasis Type 1: Can Biliary Diversion Solve These Problems?

Authors:  A S Knisely; Roderick H J Houwen
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-03-01       Impact factor: 2.839

3.  The lipid flippase heterodimer ATP8B1-CDC50A is essential for surface expression of the apical sodium-dependent bile acid transporter (SLC10A2/ASBT) in intestinal Caco-2 cells.

Authors:  Vincent A van der Mark; D Rudi de Waart; Kam S Ho-Mok; Merit M Tabbers; Heleen W Voogt; Ronald P J Oude Elferink; A S Knisely; Coen C Paulusma
Journal:  Biochim Biophys Acta       Date:  2014-09-16

4.  Total internal biliary diversion during liver transplantation for type 1 progressive familial intrahepatic cholestasis: a novel approach.

Authors:  V P Mali; A Fukuda; T Shigeta; H Uchida; Y Hirata; T H Rahayatri; H Kanazawa; K Sasaki; J de Ville de Goyet; M Kasahara
Journal:  Pediatr Transplant       Date:  2016-08-17

5.  Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation.

Authors:  Panayotis Lykavieris; Saskia van Mil; Danièle Cresteil; Monique Fabre; Michelle Hadchouel; Leo Klomp; Olivier Bernard; Emmanuel Jacquemin
Journal:  J Hepatol       Date:  2003-09       Impact factor: 25.083

6.  A Novel Truncation Mutation in ATP8B1 Gene in Progressive Familial Intrahepatic Cholestasis.

Authors:  Anjali Sharma; Ujjal Poddar; Shikha Agnihotry; Rakesh Aggarwal
Journal:  Indian Pediatr       Date:  2016-12-15       Impact factor: 1.411

7.  Spectrum of genomic variations in Indian patients with progressive familial intrahepatic cholestasis.

Authors:  Anjali Sharma; Ujjal Poddar; Shikha Agnihotry; Shubha R Phadke; Surender K Yachha; Rakesh Aggarwal
Journal:  BMC Gastroenterol       Date:  2018-07-04       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.